← All Metsera, INC filings

Metsera, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

MTSR
Metsera, INC
SCHEDULE: Metsera Acquired by Pfizer; ARCH Ventures Exits Stake
ARCH Venture Funds and associated individuals ceased to be 5% beneficial owners of Metsera, Inc. following its acquisition by Pfizer Inc. for $65.60 cash per share plus a contingent value right.
MTSR
Metsera, INC
SCHEDULE 13D: ARCH Venture Funds Disclose Significant 25.5% Stake in Metsera, Inc. Following IPO
ARCH Venture Funds and affiliated entities have disclosed a substantial beneficial ownership of 25.5% in Metsera, Inc. common stock, acquired through a series of preferred stock conversions and recent IPO purchases for investment purposes.